Lyme disease infects a minimum of 300,000 people per year in the United States and millions more throughout the rest of the world. Symptoms run from mild lethargy to severe arthritis to heart disease to incapacitating mental dysfunction. Although tests have improved over the past decade, they are still not completely reliable, and antibiotics are only partially effective. Up to thirty-five percent of those infected will not respond to antibiotic treatment or will relapse. The spirochetes that cause Lyme are stealth pathogens―they can hide within cells or alter their form so that our immune systems cannot find them, as well as inhibit the effectiveness of antibiotics. Lyme disease is, in fact, a potent emerging epidemic disease for which technological medicine is only partially effective. The coinfections that accompany Lyme are often as, or more, incapacitating than Lyme itself. Worldwide, hundreds of millions experience infection with babesia, bartonella, ehrlichia, anaplasma, mycoplasma, chlamydia, and the spotted fever rickettsiosis.